ID   KKCC1_HUMAN             Reviewed;         505 AA.
AC   Q8N5S9; Q9BQH3;
DT   07-DEC-2004, integrated into UniProtKB/Swiss-Prot.
DT   07-DEC-2004, sequence version 2.
DT   12-APR-2017, entry version 141.
DE   RecName: Full=Calcium/calmodulin-dependent protein kinase kinase 1;
DE            Short=CaM-KK 1;
DE            Short=CaM-kinase kinase 1;
DE            Short=CaMKK 1;
DE            EC=2.7.11.17;
DE   AltName: Full=CaM-kinase IV kinase;
DE   AltName: Full=Calcium/calmodulin-dependent protein kinase kinase alpha;
DE            Short=CaM-KK alpha;
DE            Short=CaM-kinase kinase alpha;
DE            Short=CaMKK alpha;
GN   Name=CAMKK1; Synonyms=CAMKKA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RA   Harvey M., Carra S., Tascedda F., Barden N.;
RT   "Characterization of human CaMKK alpha gene structure.";
RL   Submitted (SEP-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Amygdala;
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   GLY-375.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION IN PHOSPHORYLATION OF CAMK1D.
RX   PubMed=12935886; DOI=10.1016/S0014-5793(03)00817-2;
RA   Ishikawa Y., Tokumitsu H., Inuzuka H., Murata-Hori M., Hosoya H.,
RA   Kobayashi R.;
RT   "Identification and characterization of novel components of a
RT   Ca2+/calmodulin-dependent protein kinase cascade in HeLa cells.";
RL   FEBS Lett. 550:57-63(2003).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-458, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-492, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-67 AND SER-458, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-458, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11]
RP   VARIANT [LARGE SCALE ANALYSIS] GLY-375.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Calcium/calmodulin-dependent protein kinase that belongs
CC       to a proposed calcium-triggered signaling cascade involved in a
CC       number of cellular processes. Phosphorylates CAMK1, CAMK1D, CAMK1G
CC       and CAMK4. Involved in regulating cell apoptosis. Promotes cell
CC       survival by phosphorylating AKT1/PKB that inhibits pro-apoptotic
CC       BAD/Bcl2-antagonist of cell death. {ECO:0000269|PubMed:12935886}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Activated by Ca(2+)/calmodulin. Binding of
CC       calmodulin may relieve intrasteric autoinhibition. Partially
CC       inhibited upon phosphorylation by PRCAKA/PKA (By similarity). May
CC       be regulated through phosphorylation by CAMK1 and CAMK4.
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with CAMK4 and calmodulin. {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q04917:YWHAH; NbExp=5; IntAct=EBI-6424030, EBI-306940;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=A, Variant 3;
CC         IsoId=Q8N5S9-1; Sequence=Displayed;
CC       Name=2; Synonyms=B, Variant 1;
CC         IsoId=Q8N5S9-2; Sequence=VSP_012140, VSP_012141;
CC   -!- DOMAIN: The autoinhibitory domain overlaps with the calmodulin
CC       binding region and may be involved in intrasteric autoinhibition.
CC   -!- DOMAIN: The RP domain (arginine/proline-rich) is involved in the
CC       recognition of CAMKI and CAMK4 as substrates. {ECO:0000250}.
CC   -!- PTM: Appears to be autophosphorylated in a Ca(2+)/calmodulin-
CC       dependent manner. Phosphorylated at multiple sites by PRCAKA/PKA.
CC       Phosphorylation of Ser-458 is blocked upon binding to
CC       Ca(2+)/calmodulin. In vitro, phosphorylated by CAMK1 and CAMK4 (By
CC       similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr
CC       protein kinase family. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF425232; AAN37386.1; -; mRNA.
DR   EMBL; AF425301; AAN37387.1; -; mRNA.
DR   EMBL; AL136576; CAB66511.1; -; mRNA.
DR   EMBL; BC031647; AAH31647.1; -; mRNA.
DR   EMBL; BC043487; AAH43487.1; -; mRNA.
DR   CCDS; CCDS11038.1; -. [Q8N5S9-1]
DR   CCDS; CCDS11039.1; -. [Q8N5S9-2]
DR   RefSeq; NP_115670.1; NM_032294.2. [Q8N5S9-1]
DR   RefSeq; NP_757343.2; NM_172206.1.
DR   RefSeq; NP_757344.2; NM_172207.2. [Q8N5S9-2]
DR   RefSeq; XP_016880709.1; XM_017025220.1. [Q8N5S9-1]
DR   UniGene; Hs.8417; -.
DR   ProteinModelPortal; Q8N5S9; -.
DR   SMR; Q8N5S9; -.
DR   BioGrid; 123981; 24.
DR   IntAct; Q8N5S9; 16.
DR   MINT; MINT-3040241; -.
DR   BindingDB; Q8N5S9; -.
DR   ChEMBL; CHEMBL5256; -.
DR   GuidetoPHARMACOLOGY; 1956; -.
DR   iPTMnet; Q8N5S9; -.
DR   PhosphoSitePlus; Q8N5S9; -.
DR   BioMuta; CAMKK1; -.
DR   DMDM; 56404620; -.
DR   EPD; Q8N5S9; -.
DR   MaxQB; Q8N5S9; -.
DR   PeptideAtlas; Q8N5S9; -.
DR   PRIDE; Q8N5S9; -.
DR   TopDownProteomics; Q8N5S9-2; -. [Q8N5S9-2]
DR   DNASU; 84254; -.
DR   Ensembl; ENST00000158166; ENSP00000158166; ENSG00000004660. [Q8N5S9-2]
DR   Ensembl; ENST00000348335; ENSP00000323118; ENSG00000004660. [Q8N5S9-1]
DR   GeneID; 84254; -.
DR   KEGG; hsa:84254; -.
DR   UCSC; uc002fwu.4; human. [Q8N5S9-1]
DR   CTD; 84254; -.
DR   DisGeNET; 84254; -.
DR   GeneCards; CAMKK1; -.
DR   H-InvDB; HIX0135620; -.
DR   HGNC; HGNC:1469; CAMKK1.
DR   HPA; CAB009111; -.
DR   HPA; HPA028062; -.
DR   MIM; 611411; gene.
DR   neXtProt; NX_Q8N5S9; -.
DR   OpenTargets; ENSG00000004660; -.
DR   PharmGKB; PA26051; -.
DR   GeneTree; ENSGT00530000063214; -.
DR   HOGENOM; HOG000007846; -.
DR   HOVERGEN; HBG052262; -.
DR   InParanoid; Q8N5S9; -.
DR   KO; K00908; -.
DR   PhylomeDB; Q8N5S9; -.
DR   TreeFam; TF313013; -.
DR   Reactome; R-HSA-442717; CREB phosphorylation through the activation of CaMKK.
DR   SignaLink; Q8N5S9; -.
DR   SIGNOR; Q8N5S9; -.
DR   ChiTaRS; CAMKK1; human.
DR   GeneWiki; CAMKK1; -.
DR   GenomeRNAi; 84254; -.
DR   PMAP-CutDB; Q8N5S9; -.
DR   PRO; PR:Q8N5S9; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000004660; -.
DR   CleanEx; HS_CAMKK1; -.
DR   ExpressionAtlas; Q8N5S9; baseline and differential.
DR   Genevisible; Q8N5S9; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005516; F:calmodulin binding; IBA:GO_Central.
DR   GO; GO:0004683; F:calmodulin-dependent protein kinase activity; IBA:GO_Central.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IBA:GO_Central.
DR   GO; GO:0018107; P:peptidyl-threonine phosphorylation; IBA:GO_Central.
DR   GO; GO:0045860; P:positive regulation of protein kinase activity; IBA:GO_Central.
DR   InterPro; IPR020636; Ca/CaM-dep_Ca-dep_prot_Kinase.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR24347; PTHR24347; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Calmodulin-binding;
KW   Complete proteome; Cytoplasm; Kinase; Methylation; Nucleotide-binding;
KW   Nucleus; Phosphoprotein; Polymorphism; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    505       Calcium/calmodulin-dependent protein
FT                                kinase kinase 1.
FT                                /FTId=PRO_0000086141.
FT   DOMAIN      128    409       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     134    142       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   REGION      167    189       RP domain.
FT   REGION      435    440       Autoinhibitory domain. {ECO:0000250}.
FT   REGION      438    463       Calmodulin-binding. {ECO:0000250}.
FT   ACT_SITE    275    275       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING     157    157       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES      67     67       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      74     74       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8VBY2}.
FT   MOD_RES      78     78       Asymmetric dimethylarginine.
FT                                {ECO:0000250|UniProtKB:Q8VBY2}.
FT   MOD_RES     100    100       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8VBY2}.
FT   MOD_RES     108    108       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P97756}.
FT   MOD_RES     458    458       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     475    475       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P97756}.
FT   MOD_RES     492    492       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   VAR_SEQ     228    228       L -> LALQNQAQNIQLDSTNIAKPHSLLPSEQQDSGSTWA
FT                                ARS (in isoform 2).
FT                                {ECO:0000303|PubMed:11230166,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.1}.
FT                                /FTId=VSP_012140.
FT   VAR_SEQ     483    505       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:11230166,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.1}.
FT                                /FTId=VSP_012141.
FT   VARIANT     375    375       E -> G (in dbSNP:rs7214723).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_020531.
SQ   SEQUENCE   505 AA;  55735 MW;  92A055D20E487C86 CRC64;
     MEGGPAVCCQ DPRAELVERV AAIDVTHLEE ADGGPEPTRN GVDPPPRARA ASVIPGSTSR
     LLPARPSLSA RKLSLQERPA GSYLEAQAGP YATGPASHIS PRAWRRPTIE SHHVAISDAE
     DCVQLNQYKL QSEIGKGAYG VVRLAYNESE DRHYAMKVLS KKKLLKQYGF PRRPPPRGSQ
     AAQGGPAKQL LPLERVYQEI AILKKLDHVN VVKLIEVLDD PAEDNLYLVF DLLRKGPVME
     VPCDKPFSEE QARLYLRDVI LGLEYLHCQK IVHRDIKPSN LLLGDDGHVK IADFGVSNQF
     EGNDAQLSST AGTPAFMAPE AISDSGQSFS GKALDVWATG VTLYCFVYGK CPFIDDFILA
     LHRKIKNEPV VFPEEPEISE ELKDLILKML DKNPETRIGV PDIKLHPWVT KNGEEPLPSE
     EEHCSVVEVT EEEVKNSVRL IPSWTTVILV KSMLRKRSFG NPFEPQARRE ERSMSAPGNL
     LVKEGFGEGG KSPELPGVQE DEAAS
//
